Metagenome-assembled genome catalog obntained using stool metagenomes of melanoma petients

Stool metagenomes from seven published studies were used for obtained of metagenome-assembled genome catalog [Frankel et al., 2017; Gopalakrishnan et al., 2018; Matson et al., 2018; Baruch et al., 2021; Davar et al., 2021; Spencer et al., 2021; Lee et al., 2022].References:1) Frankel, Arthur E., et al. "Metagenomic shotgun sequencing and unbiased metabolomic profiling identify specific human gut microbiota and metabolites associated with immune checkpoint therapy efficacy in melanoma patients." Neoplasia 19.10 (2017): 848-855.2) Gopalakrishnan, Vancheswaran, et al. "Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients." Science 359.6371 (2018): 97-103.3) Matson, Vyara, et al. "The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients." <i>Science</i> 359.6371 (2018): 104-108.4) Baruch, Erez N., et al. "Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients." Science 371.6529 (2021): 602-609.5) Davar, Diwakar, et al. "Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients." Science 371.6529 (2021): 595-602.6) Lee, Karla A., et al. "Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma." Nature Medicine 28.3 (2022): 535-544.7) Spencer, Christine N., et al. "Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response." Science 374.6575 (2021): 1632-1640.